Product Added to Cart!
$865.20

FREE
SHIPPING

100% MONEY
BACK GUARANTEE

ONLINE
SUPPORT 24/7

Available on backorder. Please allow 2-3 weeks for production.
Sku CI02588_25_G
Chem Impex
Get Bulk Quote

Product Information

Product Name
Fmoc-3-(2-naphthyl)-L-alanine
Brand Name
Chem Impex
Product Number
02588
CAS
112883-43-9
Certificate of Analysis (COA)​
COA not found

General Information

PubChem CID
2734452
IUPAC Name
(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-naphthalen-2-ylpropanoic acid
InChI Key
JYUTZJVERLGMQZ-SANMLTNESA-N
SMILES
C1=CC=C2C=C(C=CC2=C1)CC@@H(C(=O)O)NC(=O)OCC3C4=CC=CC=C4C5=CC=CC=C35

Description

Fmoc-3-(2-naphthyl)-L-alanine is widely utilized in research focused on

Peptide Synthesis: This compound serves as a key building block in the synthesis of peptides, particularly in solid-phase peptide synthesis, allowing for the creation of complex peptide sequences with high purity.

Drug Development: Its unique structure makes it valuable in the pharmaceutical industry for developing novel drug candidates that target specific biological pathways, enhancing therapeutic efficacy.

Bioconjugation: The chemical is used in bioconjugation techniques, facilitating the attachment of biomolecules to surfaces or other molecules, which is crucial in creating targeted drug delivery systems.

Research in Cancer Therapeutics: Researchers leverage its properties in studies aimed at developing cancer treatments, particularly those that involve targeting specific cancer cell receptors.

Fluorescent Probes: The naphthyl group in this compound can be utilized to create fluorescent probes for imaging applications, aiding in the visualization of cellular processes in biological research.

References Data Source From Pubchem

Enhancing the Half-Life of ODAP-Urea Based Radioligands by Incorporating Albumin-Binding Moieties

Publication Name: Molecular Imaging and Biology
Publication Date: 2025-08-07
DOI: 10.1007/s11307-025-02035-y

Motixafortide acetate

Publication Name: Pharmaceutical Substances
Publication Date: 2025

Development of a homotrimeric PSMA radioligand based on the NOTI chelating platform

Publication Name: EJNMMI Radiopharmacy and Chemistry
Publication Date: 2024-12-11
DOI: 10.1186/s41181-024-00314-7

Targeting Several Biologically Reported Targets of Glioblastoma Multiforme by Assaying 2D and 3D Cultured Cells

Publication Name: Cellular and Molecular Neurobiology
Publication Date: 2021-03-19
DOI: 10.1007/s10571-021-01072-9

Iron binding β-hairpin peptides

Publication Name: Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine
Publication Date: 2013-06-14
DOI: 10.1007/s10534-013-9638-y